Jerusalem
Israel
8
2025-09-25
1
2025-07-08
These are the the leading inventors for applications assigned to SpliSense Ltd.:
SpliSense Ltd. based in Jerusalem, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MUC5AC-TARGETED ANTISENSE OLIGONUCLEOTIDES AND RELATED METHODS FOR MODULATING MUCIN EXPRESSION
#2 | 2024-12-12MUC5B-TARGETED ANTISENSE OLIGONUCLEOTIDES AND RELATED METHODS FOR MODULATING MUCIN EXPRESSION
#3 | 2024-10-24 ✅ Patent 12,351,803 granted on 2025-07-08RESTORATION OF THE CFTR FUNCTION BY SPLICING MODULATION
#4 | 2023-05-11COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
#5 | 2022-07-14COMBINATION TREATMENTS FOR CYSTIC FIBROSIS CHARACTERIZED BY A 3849 + 10KB C-TO-T CFTR MUTATION
#6 | 2022-07-07RESTORATION OF THE CFTR FUNCTION BY SPLICING MODULATION
#7 | 2022-03-03COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
#8 | 2022-02-10COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
Also check out SpliSense Ltd.'s (Jerusalem, Israel) applicant profile with 3 patent applications submitted.
320354 ⎘